ISRCTN94834276已完成不适用
Randomised trial of monotherapy with tacrolimus versus triple therapy with tacrolimus azathioprine and steroids
Royal Free Hampstead NHS Trust (UK)0 个研究点目标入组 110 人开始时间: 2008年7月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •From January 2000 to June 2007, in three liver transplant centres, (Royal Free Hospital, Edinburgh Royal Infirmary and St Vincents Hospital, Dublin; all using the same donor pool) consecutive transplant recipients were randomised if they:
- •1. Had cirrhosis
- •2. Were hepatitis C virus ribonucleic acid (HCV RNA) positive in serum
- •3. Had previous histology confirming HCV-related disease
- •4. Had possible or confirmed/concomitant alcoholic aetiology or hepatocellular carcinoma (HCC)
- •5. Were older than 18 years, either sex
- •6. Had given informed written consent (at listing for transplantation)
- •7. Received a cadaveric liver transplant
排除标准
- •1. Retransplantation
- •2. Multi-organ, split or auxiliary transplants
- •3. Contraindications to tacrolimus or azathioprine
- •4. Refusal to participate
研究者
相似试验
已完成
不适用
A randomized controlled study of tacrolimus for the treatment of idiopathic membranous nephropathyIdiopathic membranous nephropathyUrological and Genital DiseasesISRCTN17977921The First Affiliated Hospital of Zhengzhou University (China)120
进行中（未招募）
1 期
A randomised prospective trial of tacrolimus-based steroid avoidance in renal transplantation with either alemtuzumab induction or, basiliximab induction and mycophenolate mofetil maintenance therapy - SALAMIMabCampath / Alemtuzumab will be used as part of the immunosuppression regime following renal transplant.EUCTR2006-000830-11-GBeeds Teaching Hospitals NHS Trust120
招募中
不适用
Clinical trial in assigning of tacrolimus dosage regimen according to CYP3A5 genotype in kidney transplant recipientsKidney transplatation patientsTCTR20131019001The National Science and Technology Development Agency140
尚未招募
2 期
Double blind, placebo controlled study Tacrolimus versus Emmolient in localized sclerodermamorphoea10010761localized sclerodermaNL-OMON31329niversitair Medisch Centrum Sint Radboud20
招募中
不适用
Examination of efficacy and safety of tacrolimus, immunomodulator for an outpatient with moderate to severe ulcerative colitisulcerative colitisJPRN-UMIN000005824Juntendo University20